Skinvisible's value lies in its ability to continually generate new IP on dermatology and medical products formulated with Invisicare®. Patent approvals are sought (initially in the U.S. and later internationally) for all products developed. There are 4 patents approved, 9 U.S. patents pending in addition to 34 PCTs internationally, with many more to be filed. Some of these PCT patents cover up to five products. All patents with Invisicare® are owned by Skinvisible.

Patent Components (Combined or Individually):

Granted Patents & Trademarks

United States Patents Granted

United States Patent No.: 6,756,059
Granted: June 29, 2004
Topical composition, topical composition precursor, and methods for manufacturing and using.

Abstract
A topical composition is provided. The topical composition can be prepared by diluting a topical composition precursor with water and adding additional components, if desired. The topical composition precursor can be prepared by melt processing a hydrophobic polymer composition that includes repeating pyrrolidone/alkylene groups wherein the alkylene groups contain at least 10 carbon atoms, and a hydrophilic polymer composition including repeating carboxylic groups and/or repeating hydroxyl groups. A topical composition precursor and methods for manufacturing and using a topical composition are provided by the invention.

United States Patent No.: 6,582,683
Granted: June 24, 2003
Dermal barrier composition.

Abstract
Disclosed is a dermal barrier composition which contains a hydrophilic polymer emulsion and a hydrophobic polymer emulsion. The dermal barrier composition is moisture activated, and remains inert until the hydrophobic and hydrophilic polymer emulsions contact a suitable substrate such as human skin. The dermal barrier composition is itself an emulsion, and can optionally contain a biocidal agent for antimicrobial and antiviral efficacy. The dermal barrier composition can also contain other active agents such as sunscreens, insect repellents and fungicides. The dermal barrier composition can be applied topically to skin, where it forms a protective or barrier layer against a number of pathogenic and chemical irritants.

International Patents Granted

India Patent No.: 2083999
Granted: July 26, 2007
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Abstract
A topical composition is provided. The topical composition can be prepared by diluting a topical composition precursor with water and adding additional components, if desired. The topical composition precursor can be prepared by melt processing a hydrophobic polymer composition that includes repeating pyrrolidone/alkylene groups wherein the alkylene groups contain at least 10 carbon atoms, and a hydrophilic polymer composition including repeating carboxylic groups and/or repeating hydroxyl groups. A topical composition precursor and methods for manufacturing and using a topical composition are provided by the invention.

Australia Patent No.:
Granted: June 3, 2008
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Abstract
A topical composition is provided. The topical composition can be prepared by diluting a topical composition precursor with water and adding additional components, if desired. The topical composition precursor can be prepared by melt processing a hydrophobic polymer composition that includes repeating pyrrolidone/alkylene groups wherein the alkylene groups contain at least 10 carbon atoms, and a hydrophilic polymer composition including repeating carboxylic groups and/or repeating hydroxyl groups. A topical composition precursor and methods for manufacturing and using a topical composition are provided by the invention.

Pending Applications Globally

There are a number of patents ending in the United States and internationally. Skinvisible continues to file for patents with each new product formulation developed, and each new Invisicare polymer delivery system.

Latest Press Releases:

November 4, 2008
Skinvisible Appoints Dr. Geert Cauwenbergh to Its International Advisory Board - A Strong International Strategy for Invisicare Is Put In Place

July 29, 2008
Skinvisible Offers 8 Hour Photostability for Parsol 1789 - UVA Sunscreen with Invisicare Available For International Licensing

June 11, 2008
Skinvisible Appoints New Vice President of Business Development & Marketing - Strategic Plan for Invisicare Strengthens

CLICK HERE TO READ ALL NEWS RELEASES

Research & Development

Technology Overview